首页> 外文会议>Clinical Histocompatibility Workshop. >CHRONIC KIDNEY ALLOGRAFT REJECTION DUE TO PRE-TRANSPLANT SENSITIZATION TO HLA-DP
【24h】

CHRONIC KIDNEY ALLOGRAFT REJECTION DUE TO PRE-TRANSPLANT SENSITIZATION TO HLA-DP

机译:慢性肾同种异体移植抑制因移植前敏化对HLA-DP

获取原文

摘要

Aim: The Immunogenicity of HLA-DP is generally focused on a few shared epitopes of the DPB1 molecule including HLA-DPB1 epitopes 55-57DED and 84-87DEAV. We report the 5-year outcome of a kidney transplant recipient who was re-grafted across an incompatible crossmatch due to donor-directed anti-HLA-DP antibodies from a Deceased Donor (DD). The patient was matched at the allele level for HLA-A, B, Cw, DRB1, DRB3, and DQB1 specificities (1). Methods: A 41 y-old Caucasian female with a history of one pregnancy and multiple blood transfusions received her first DD kidney transplant in 1986 and a 2nd DD kidney transplant in 1996 (Table 1). She was diagnosed with post-transplant lymphoproliferative disorder (PTLD) in 1997 and her immunosupressive medication was discontinued. She developed antibodies to mismatched donor Class I and Class II antigens (PRA: 40-80%). In addition, anti-HLA DP antibodies were also detected with FlowPRA single antigen bead assay. In 2005, she received a 3rd kidney from a zero A, B, Cw, DR, and DQ mismatched DD kidney transplant.
机译:目的:HLA-DP的免疫原性通常集中在DPB1分子的少数共用表位上,包括HLA-DPB1表位55-57dsd和84-87deav。我们报告了由于来自死者供体(DD)的供体导向的抗HLA-DP抗体而在不相容的交叉轨道上被重建的肾移植受体的5年结果。患者与HLA-A,B,CW,DRB1,DRB3和DQB1特异性(1)的等位基因水平相匹配。方法:1986年,一名妊娠病史和多种血液输血的历史,1996年的第一个DD肾移植,1996年的第一个DD肾移植术(表1),是41岁的白种人女性。她于1997年被诊断出患有移植后淋巴抑制性疾病(PTLD),并停止了她的免疫抑制药物。她开发了抗体匹配的供体I和II类抗原(PRA:40-80%)。此外,还通过FlowPra单抗原珠测定检测抗HLA DP抗体。 2005年,她从零A,B,CW,DR和DQ错配DD肾移植中获得第3个肾脏。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号